Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunome Inc.

5.93
-0.3100-4.97%
Post-market: 5.930.00000.00%19:49 EDT
Volume:1.11M
Turnover:6.58M
Market Cap:515.62M
PE:-1.04
High:6.20
Open:6.02
Low:5.75
Close:6.24
Loading ...

Immunome 2024 Net Loss Narrows

MT Newswires Live
·
20 Mar

Immunome reports FY24 revenue $9.04M, consensus $9.41M

TIPRANKS
·
20 Mar

Immunome Reports Full Year 2024 Financial Results and Provides Business Update

THOMSON REUTERS
·
20 Mar

Immunome Inc - Topline Data for Phase 3 Ringside Study Expected in H2 2025

THOMSON REUTERS
·
20 Mar

Immunome Inc: Projected Cash Runway Extends Into 2027

THOMSON REUTERS
·
20 Mar

Immunome FY Collaboration Revenue USD 9.041 Million

THOMSON REUTERS
·
20 Mar

Immunome Reports Full Year 2024 Financial Results and Provides Business Update

Business Wire
·
20 Mar

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
15 Mar

Immunome Initiated at Outperform by LifeSci Capital

Dow Jones
·
11 Mar

Immunome initiated with an Outperform at LifeSci Capital

TIPRANKS
·
11 Mar

BRIEF-Immunome doses first patient in early-stage trial of its experimental cancer treatment

Reuters
·
10 Mar

Immunome Doses First Patient in Phase 1 Trial of IM-1021, a Ror1-Targeted ADC

THOMSON REUTERS
·
10 Mar

Immunome Doses First Patient in Phase 1 Trial of IM-1021, a ROR1-Targeted ADC

Business Wire
·
10 Mar

Immunome to Present at Upcoming March Conferences

Business Wire
·
25 Feb

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
07 Feb

Immunome Closes Public Offering of Shares

MT Newswires Live
·
01 Feb

Immunome Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Business Wire
·
01 Feb

BUZZ-Immunome drops on $150 mln stock sale

Reuters
·
30 Jan

Immunome Prices $150 Million Stock Offering

MT Newswires Live
·
30 Jan

Immunome 19.35M share Spot Secondary priced at $7.75

TIPRANKS
·
30 Jan